Xtx Topco LTD Fate Therapeutics Inc Transaction History

Xtx Topco LTD

  • $1.12 Billion
  • Q2 2024

A detailed history of Xtx Topco LTD transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Xtx Topco LTD holds 33,898 shares of FATE stock, worth $105,761. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,898
Previous 17,388 94.95%
Holding current value
$105,761
Previous $127,000 12.6%
% of portfolio
0.01%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$3.26 - $7.08 $53,822 - $116,890
16,510 Added 94.95%
33,898 $111,000
Q1 2024

May 13, 2024
BUY
$3.54 - $8.35 $61,553 - $145,189
17,388 New
17,388 $127,000
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $346,068 - $863,457
171,321 Added 793.19%
192,920 $408,000
Q2 2023

Aug 14, 2023
SELL
$4.76 - $6.59 $31,373 - $43,434
-6,591 Reduced 23.38%
21,599 $102,000
Q1 2023

May 12, 2023
SELL
$4.24 - $11.12 $322,240 - $845,119
-76,000 Reduced 72.94%
28,190 $160,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $824,986 - $1.99 Million
83,670 Added 407.75%
104,190 $1.05 Million
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $431,740 - $739,951
20,520 New
20,520 $460,000
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $298,661 - $482,383
-5,039 Closed
0 $0
Q2 2021

Aug 12, 2021
BUY
$67.25 - $92.52 $338,872 - $466,208
5,039 New
5,039 $437,000

Others Institutions Holding FATE

# of Institutions
189
Shares Held
123M
Call Options Held
15K
Put Options Held
14K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $303M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email